BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30645856)

  • 1. [Breakthrough Point of Chinese Medicine and Pharmacy for HIV/AIDS Prevention and Treatment in the Post-HAART Period].
    Xu QL; Li QY; Jin YT; Xie SP; Xu LR; Guo HJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1128-1131. PubMed ID: 30645856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk Factors of the Mortality among Senile HIV/AIDS Patients Intervened by Comprehensive Intervention of Chinese Medicine and Pharmacy].
    Jiang ZQ; Li ZW; Wu T; Yuan J; Jin YT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Nov; 35(11):1331-4. PubMed ID: 26775480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune reconstitution related factors in patients with HIV/AIDS].
    Wang J; Lin HS; Tang YL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Dec; 29(12):1125-9. PubMed ID: 20214339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013].
    Chen S; Ma L; Lu X; Li Y; Wang W; Wang Y; Zhao C; Zhang Y; Zhao H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):460-4. PubMed ID: 26080634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development of studies on traditional Chinese medicine in prophylaxis and treatment of AIDS.
    Wu B
    J Tradit Chin Med; 1992 Mar; 12(1):10-20. PubMed ID: 1597994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the effect of treatment and the status of drug resistance among HIV/AIDS patients treated with highly active antiretroviral therapy in Shandong province].
    Zhang J; Lin B; Lin L; Yang PJ; Fu JH; Li HP; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1108-11. PubMed ID: 18396667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
    Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
    BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary complications in patients with AIDS].
    Oka S
    Kekkaku; 2002 Jan; 77(1):37-40. PubMed ID: 11855078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese medicine prevention and treatment of AIDS in terms of constitution theory].
    Zhang YP; Deng X; Li YL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1422-4. PubMed ID: 22097219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting against acquired immunodeficiency syndrome with Chinese medicine: a perspective from China.
    Tang YL; Wang J
    Chin J Integr Med; 2011 May; 17(5):323-5. PubMed ID: 21611892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection.
    Lazarus JR; Rutstein RM; Lowenthal ED
    HIV Med; 2015 Jul; 16(6):355-61. PubMed ID: 25604610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Qiling Decoction combined HAART on expression levels of Treg cells and Th17 in HIV/AIDS patients].
    Xu WF; Wu Y; Pan GS; Zhong JP; Lan SB; Chen XF; Lu QQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):157-61. PubMed ID: 24672938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell response of advanced aids patients after highly active antiretroviral therapy.
    Wang AX; Li TS; Cao YZ; Han Y; Qiu ZF; Xie J
    Chin Med Sci J; 2005 Dec; 20(4):223-5. PubMed ID: 16422247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.